Your browser doesn't support javascript.
loading
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Catenacci, Daniel V T; Kang, Yoon-Koo; Park, Haeseong; Uronis, Hope E; Lee, Keun-Wook; Ng, Matthew C H; Enzinger, Peter C; Park, Se Hoon; Gold, Philip J; Lacy, Jill; Hochster, Howard S; Oh, Sang Cheul; Kim, Yeul Hong; Marrone, Kristen A; Kelly, Ronan J; Juergens, Rosalyn A; Kim, Jong Gwang; Bendell, Johanna C; Alcindor, Thierry; Sym, Sun Jin; Song, Eun-Kee; Chee, Cheng Ean; Chao, Yee; Kim, Sunnie; Lockhart, A Craig; Knutson, Keith L; Yen, Jennifer; Franovic, Aleksandra; Nordstrom, Jeffrey L; Li, Daner; Wigginton, Jon; Davidson-Moncada, Jan K; Rosales, Minori Koshiji; Bang, Yung-Jue.
Afiliación
  • Catenacci DVT; The University of Chicago Medical Center, Chicago, IL, USA. Electronic address: dcatenac@bsd.uchicago.edu.
  • Kang YK; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Park H; Washington University School of Medicine, St Louis, MO, USA.
  • Uronis HE; Duke University Medical Center, Durham, NC, USA.
  • Lee KW; Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
  • Ng MCH; National Cancer Centre, Duke-NUS Medical School, Singapore.
  • Enzinger PC; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
  • Park SH; Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea.
  • Gold PJ; Swedish Cancer Institute, Seattle, WA, USA.
  • Lacy J; Yale School of Medicine, New Haven, CT, USA.
  • Hochster HS; Yale School of Medicine, New Haven, CT, USA.
  • Oh SC; Korea University Guro Hospital, Seoul, South Korea.
  • Kim YH; Korea University Anam Hospital, Seoul, South Korea.
  • Marrone KA; Johns Hopkins University, Baltimore, MD, USA.
  • Kelly RJ; Baylor University Medical Center, Dallas, TX, USA.
  • Juergens RA; McMaster University, Juravinski Cancer Centre, Hamilton, ON, Canada.
  • Kim JG; Kyungpook National University Chilgok Hospital, Daegu, South Korea.
  • Bendell JC; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Alcindor T; McGill University Health Centre, Montreal, QC, Canada.
  • Sym SJ; Gachon University Gil Medical Center, Incheon, South Korea.
  • Song EK; Chonbuk National University Medical School, Jeonju, South Korea.
  • Chee CE; National University Cancer Institute, Singapore.
  • Chao Y; Taipei Veterans General Hospital, Taipei, Taiwan.
  • Kim S; Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC, USA.
  • Lockhart AC; Washington University School of Medicine, St Louis, MO, USA.
  • Knutson KL; Mayo Clinic, Jacksonville, FL, USA.
  • Yen J; Guardant Health, Inc., Redwood City, CA, USA.
  • Franovic A; Guardant Health, Inc., Redwood City, CA, USA.
  • Nordstrom JL; MacroGenics, Rockville, MD, USA.
  • Li D; MacroGenics, Rockville, MD, USA.
  • Wigginton J; MacroGenics, Rockville, MD, USA.
  • Davidson-Moncada JK; MacroGenics, Rockville, MD, USA.
  • Rosales MK; MacroGenics, Rockville, MD, USA.
  • Bang YJ; Seoul National University College of Medicine, Seoul, South Korea.
Lancet Oncol ; 21(8): 1066-1076, 2020 08.
Article en En | MEDLINE | ID: mdl-32653053

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article